Investment company I Love Lund invests approximately SEK 1.5 million in life science company Aligned Bio through a rights issue. This is stated in a press release.I Love Lund subscribes for 3,200 shares at a price of SEK 481 per share and will have an ownership stake of just under 1.4 percent after the issue. In total, Aligned Bio has raised SEK 35 million in the financing round, which was led by LMK Forward.The capital will be used to accelerate commercialization during 2026 and 2027, primarily within next-generation sequencing and ultrasensitive protein detection.Aligned Bio becomes I Love Lund's second outright new investment during 2026. The investment was made at the beginning of the third quarter.